EMDA is a non-invasive and painless system for local drug administration, which provides significantly greater clinical efficacy than that achieved with passive, systemic or thermotherapy diffusion, without the side effects of systemic administration.

The EMDA system is presented as an effective option to improve intravesical chemotherapy treatment, according to the European Guidelines of the EAU (European Association of Urology).

EMDA is based on the principle of electroosmosis and iontophoresis, achieving drug penetration 700-800% higher than the normal transdermal route, but without its side effects, reducing the recurrence of bladder tumors by 35%.